Literature DB >> 14236225

PLASMA CLEARANCE OF DL-BETA-H3-NOREPINEPHRINE IN NORMAL HUMAN SUBJECTS AND PATIENTS WITH ESSENTIAL HYPERTENSION.

S E GITLOW, M MENDLOWITZ, E K WILK, S WILK, R L WOLF, N E NAFTCHI.   

Abstract

Entities:  

Keywords:  BLOOD; HYPERTENSION; METABOLISM; NOREPINEPHRINE; TRITIUM

Mesh：

Substances：

Year:  1964        PMID： 14236225      PMCID： PMC289646          DOI： 10.1172/JCI105075

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  21 in total

1.  Effect of drugs on the uptake and metabolism of H3-norepinephrine.

Authors:  G HERTING; J AXELROD; L G WHITBY
Journal:  J Pharmacol Exp Ther       Date:  1961-11       Impact factor: 4.030

2.  Supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U TRENDELENBURG
Journal:  Pharmacol Rev       Date:  1963-06       Impact factor: 25.468

3.  Urinary excretion of catecholamines and their metabolites in pheochromocytoma.

Authors:  J R CROUT; J J PISANO; A SJOERDSMA
Journal:  Am Heart J       Date:  1961-03       Impact factor: 4.749

4.  Different pools of catecholamines stored in the adrenal medulla.

Authors:  N A HILLARP
Journal:  Acta Physiol Scand       Date:  1960-09-30

5.  Uptake of tritium-labeled norepinephrine in brain and other tissues of cat in vitro.

Authors:  H J DENGLER; H E SPIEGEL; E O TITUS
Journal:  Science       Date:  1961-04-07       Impact factor: 47.728

6.  Essential hypertension and inheritance of vascular reactivity.

Authors:  A E DOYLE; J R FRASER
Journal:  Lancet       Date:  1961-09-02       Impact factor: 79.321

7.  The physiological disposition of H3-epinephrine and its metabolite metanephrine.

Authors:  J AXELROD; H WEIL-MALHERBE; R TOMCHICK
Journal:  J Pharmacol Exp Ther       Date:  1959-12       Impact factor: 4.030

8.  Excretion of noradrenaline in urine in hypertension.

Authors:  U S VON EULER; S HELLNER; A PURKHOLD
Journal:  Scand J Clin Lab Invest       Date:  1954       Impact factor: 1.713

9.  THE NATURE OF THE PERIPHERAL RESISTANCE IN ARTERIAL HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOMOTOR SYSTEM.

Authors:  M Prinzmetal; C Wilson
Journal:  J Clin Invest       Date:  1936-01       Impact factor: 14.808

10.  [Experimental studies on serpasil (reserpin) a new and very effective Rauwolfia alkaloid with analeptic effect].

Authors:  H J BEIN; F GROSS; J TRIPOD; R MEIER
Journal:  Schweiz Med Wochenschr       Date:  1953-10-17
View more
  8 in total

1.  Adrenergic mechanisms in hypertension.

Authors:  M J Davey; H Reinert
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

2.  [Catecholamine synthesis in desoxycorticosterone hypertension of the rat].

Authors:  H Liebau; A Distler
Journal:  Klin Wochenschr       Date:  1969-03-01

3.  Emotional stress in hypertension.

Authors: 
Journal:  Br Med J       Date:  1971-07-31

4.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

5.  Norepinephrine clearance and pressor effect in normal and hypertensive man.

Authors:  M Grimm; P Weidmann; G Keusch; A Meier; Z Glück
Journal:  Klin Wochenschr       Date:  1980-11-03

6.  An assessment of the role of the sympathetic nervous system in experimental hypertension using normal and immunosympathectomized rats.

Authors:  E Ayitey-Smith; D R Varma
Journal:  Br J Pharmacol       Date:  1970-10       Impact factor: 8.739

7.  Catecholamine turnover in normotensive and hypertensive man: effects of antiadrenergic drugs.

Authors:  V DeQuattro; A Sjoerdsma
Journal:  J Clin Invest       Date:  1968-10       Impact factor: 14.808

8.  Human norepinephrine metabolism. Its evaluation bydministration of tritiated norepinephrine.

Authors:  S E Gitlow; M Mendlowitz; L M Bertani; S Wilk
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.